STAAR Surgical Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8523123052
USD
26.60
0.68 (2.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About STAAR Surgical Co. stock-summary
stock-summary
STAAR Surgical Co.
Pharmaceuticals & Biotechnology
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29, 2017, the Company sold its products in over 75 countries, with distribution in the United States, Canada, Japan and Spain.
Company Coordinates stock-summary
Company Details
25651 Atlantic Ocean Drive , LAKE FOREST CA : 92630
stock-summary
Tel: 1 626 30379021 626 3037902
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 71 Schemes (42.88%)

Foreign Institutions

Held by 131 Foreign Institutions (23.16%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Louis Silverman
Independent Chairman of the Board
Ms. Caren Mason
President, Chief Executive Officer, Director
Mr. Thomas Frinzi
Director
Dr. Gilbert Kliman
Director
Mr. Stephen Farrell
Independent Director
Mr. John Moore
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
44 Million
(Quarterly Results - Jun 2025)
Net Profit:
-17 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,372 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.55

stock-summary
Return on Equity

-26.75%

stock-summary
Price to Book

4.08